Generate Investment Management’s Boston Scientific BSX Stock Holding History

Generate Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-254,250	Closed	-$16M	–	94
2026 Q1	$16M	Sell	254,250 -94,670	-27%	-$7.57M	0.79%	30
2025 Q4	$33.3M	Sell	348,920 -46,161	-12%	-$4.53M	1.52%	18
2025 Q3	$38.6M	Buy	395,081 +259,265	+191%	+$26.8M	1.96%	14
2025 Q2	$14.6M	Sell	135,816 -3,875	-3%	-$392K	0.81%	39
2025 Q1	$14.1M	Sell	139,691 -43,287	-24%	-$4.36M	0.99%	35
2024 Q4	$16.3M	Sell	182,978 -2,958	-2%	-$260K	1.14%	31
2024 Q3	$15.6M	Sell	185,936 -36,153	-16%	-$2.85M	1.04%	35
2024 Q2	$17.1M	Buy	222,089 +46,042	+26%	+$3.37M	1.01%	29
2024 Q1	$12.1M	Sell	176,047 -79,543	-31%	-$5.11M	0.87%	36
2023 Q4	$14.8M	Buy	+255,590	New	+$13.6M	1.28%	29

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Generate Investment Management's BSX Position: Q2 2026 in Review

Generate Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 254,250 shares — an estimated $16M sold.

Generate Investment Management first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $38.6M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Generate Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Generate Investment Management sold 254,250 Boston Scientific shares in Q2 2026, an estimated $16M.
Generate Investment Management first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
Generate Investment Management's Boston Scientific position peaked at $38.6M in Q3 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Generate Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.